These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 28472900)
1. The Long-Term Effects of Antipsychotic Medication on Clinical Course in Schizophrenia. Goff DC; Falkai P; Fleischhacker WW; Girgis RR; Kahn RM; Uchida H; Zhao J; Lieberman JA Am J Psychiatry; 2017 Sep; 174(9):840-849. PubMed ID: 28472900 [TBL] [Abstract][Full Text] [Related]
2. Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era. Alvarez-Jimenez M; O'Donoghue B; Thompson A; Gleeson JF; Bendall S; Gonzalez-Blanch C; Killackey E; Wunderink L; McGorry PD CNS Drugs; 2016 May; 30(5):357-68. PubMed ID: 27106296 [TBL] [Abstract][Full Text] [Related]
3. Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach. Glick ID; Correll CU; Altamura AC; Marder SR; Csernansky JG; Weiden PJ; Leucht S; Davis JM J Clin Psychiatry; 2011 Dec; 72(12):1616-27. PubMed ID: 22244023 [TBL] [Abstract][Full Text] [Related]
4. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention. Francey SM; Nelson B; Thompson A; Parker AG; Kerr M; Macneil C; Fraser R; Hughes F; Crisp K; Harrigan S; Wood SJ; Berk M; McGorry PD Schizophr Res; 2010 Jun; 119(1-3):1-10. PubMed ID: 20347270 [TBL] [Abstract][Full Text] [Related]
5. [Is our clinical practice of antipsychotic relapse prevention in schizophrenia really evidence-based]. Schanda H; Stompe T Neuropsychiatr; 2010; 24(1):14-26. PubMed ID: 20146916 [TBL] [Abstract][Full Text] [Related]
7. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness]. Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM; Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369 [TBL] [Abstract][Full Text] [Related]
8. Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia. A Randomized Clinical Trial. Subotnik KL; Casaus LR; Ventura J; Luo JS; Hellemann GS; Gretchen-Doorly D; Marder S; Nuechterlein KH JAMA Psychiatry; 2015 Aug; 72(8):822-9. PubMed ID: 26107752 [TBL] [Abstract][Full Text] [Related]
9. Aripiprazole in schizophrenia and schizoaffective disorder: A review. Stip E; Tourjman V Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550 [TBL] [Abstract][Full Text] [Related]
10. First-episode schizophrenia. Early intervention and medication discontinuation in the context of course and treatment. Wyatt RJ; Damiani LM; Henter ID Br J Psychiatry Suppl; 1998; 172(33):77-83. PubMed ID: 9764131 [TBL] [Abstract][Full Text] [Related]
11. What do large scale studies of medication in schizophrenia add to our management strategies? Agius M; Davis A; Gilhooley M; Chapman S; Zaman R Psychiatr Danub; 2010 Jun; 22(2):323-8. PubMed ID: 20562774 [TBL] [Abstract][Full Text] [Related]
12. Model of Management (Mo.Ma) for the patient with schizophrenia: crisis control, maintenance, relapse prevention, and recovery with long-acting injectable antipsychotics (LAIs). Brugnoli R; Rapinesi C; Kotzalidis GD; Marcellusi A; Mennini FS; De Filippis S; Carrus D; Ballerini A; Francomano A; Ducci G; Del Casale A; Girardi P Riv Psichiatr; 2016; 51(2):47-59. PubMed ID: 27183509 [TBL] [Abstract][Full Text] [Related]
13. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [TBL] [Abstract][Full Text] [Related]
14. Choice of maintenance medication for schizophrenia. Davis JM; Chen N J Clin Psychiatry; 2003; 64 Suppl 16():24-33. PubMed ID: 14680416 [TBL] [Abstract][Full Text] [Related]
15. Long-acting injectable antipsychotics in early psychosis: a literature review. Emsley R; Chiliza B; Asmal L; Mashile M; Fusar-Poli P Early Interv Psychiatry; 2013 Aug; 7(3):247-54. PubMed ID: 23342964 [TBL] [Abstract][Full Text] [Related]
16. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine. Krzystanek M; Krupka-Matuszczyk I Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416 [TBL] [Abstract][Full Text] [Related]
17. Reviewing depot injection efficacy in the treatment of schizophrenia. Jones A; Jones M Nurs Stand; 2016 Apr; 30(33):50-9. PubMed ID: 27073965 [TBL] [Abstract][Full Text] [Related]
19. Upcoming agents for the treatment of schizophrenia: mechanism of action, efficacy and tolerability. Bishara D; Taylor D Drugs; 2008; 68(16):2269-92. PubMed ID: 18973393 [TBL] [Abstract][Full Text] [Related]
20. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice. Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]